Transfusion Medicine · 2009 · 13 citations · 17 references
MedicineHematologyInfectious DiseasesPrion DiseasesRadiation ProtectionTransfusion MedicineBiological Effects Of RadiationCell Quality ControlPrion Disease PreventionRed Blood Cell TransfusionBlood Product IrradiationBlood Product SafetyControl Group DesignIrradiation Of Blood ProductsMatched Control GroupProthrombin ActivationRed Blood Cell ConcentratesRed Blood Cell Hemolysis
This study investigated whether filtration of leucodepleted red cells in SAG-M through the P-CAPT filter in order to prevent the potential risk of vCJD infection associated with prion transmission through transfusion has any deleterious effect on red-cell quality. Bottom-and-top SAG-M leucodepleted red-cell concentrates (24 units) were prion-reduction filtered on the day following collection, with half of the units undergoing irradiation on day 14. A control group (12 units) was not prion filtered. Units were sampled at 7-day intervals up to day 35 and tested using standard measures of red-cell quality as well as prothrombin content (to examine prion filter efficacy). Haemoglobin loss per unit was approximately 9 g and in some cases levels were below standard specification (40 g). Haemolysis increased significantly after filtration [0.01 (0.00-0.05) vs. 0.23 (0.07-0.52, p<0.001)]. Prothrombin levels were reduced 41.6-fold compared to leucodepleted red-cell units. Product specifications were within or close to routine acceptable levels. Owing to the reduction in haemoglobin levels below those specified, it may be preferable to reduce haemoglobin specification levels and transfuse more prion-filtered units rather than transfuse potentially unsafe blood product. The risk of transfusing more units with less haemoglobin should be offset against the risk of transfusing unfiltered blood.
17
Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion
C. A. Llewelyn, P. B Hewitt, RSG Knight et al. · The Lancet · 2004 · 1.1K citations
Preclinical vCJD after blood transfusion in a PRNP codon 129 heterozygous patient
Alexander Peden, Mark Head, L Ritchie Diane et al. · The Lancet · 2004 · 854 citations
Guide to the Preparation, Use and Quality Assurance of Blood Components.
Napier · Transfusion Medicine · 1998 · 679 citations
Medicine, Biochemistry, Hematology +14
A crucial role for B cells in neuroinvasive scrapie
Michael A. Klein, Rico Frigg, Eckhard Flechsig et al. · Nature · 1997 · 498 citations
Life Sciences, Immunology, Neurology +15